Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Birchler Brian
Apr 17 17:21 ET
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Baroldi Joseph
Apr 17 17:20 ET
Ionis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 16 21:01 ET
Ionis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 16 20:51 ET
Ionis Pharmaceuticals | 8-K: Current report
Apr 8 06:07 ET
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Jenne Kyle
Mar 13 17:55 ET
Ionis Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Jenne Kyle
Mar 13 17:55 ET
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Swayze Eric
Mar 4 19:16 ET
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Monia Brett P
Mar 4 19:16 ET
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Geary Richard S
Mar 4 19:16 ET
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Birchler Brian
Mar 4 19:16 ET
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer BENNETT C FRANK
Mar 4 19:16 ET
Ionis Pharmaceuticals | 8-K: Current report
Feb 29 09:13 ET
Ionis Pharmaceuticals | 10-K: Annual report
Feb 21 16:46 ET
Ionis Pharmaceuticals | 8-K: Ionis reports fourth quarter and full year 2023 financial results
Feb 21 11:20 ET
Ionis Pharmaceuticals | 144/A: Others
Feb 20 10:43 ET
Ionis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Monia Brett P
Feb 16 19:52 ET
Ionis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 16 16:39 ET
Ionis Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. Rowe Price Investment Management, Inc.(9.2%)
Feb 14 10:20 ET
Ionis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.90%)
Feb 13 17:49 ET
No Data
No Data